Richard DeLuca - Merck President

MRK Stock  MXN 1,977  43.00  2.13%   

President

Mr. Richard R. DeLuca, Jr. is Executive Vice President and President Merck Animal Health of Merck Co Inc. He is responsible for the Merck Animal Health organization. Prior to September 2011, Mr. DeLuca was Chief Financial Officer, Becton Dickinson Biosciences since 2010 and President, Wyeths Fort Dodge Animal Health division from 2007 to 2010. He served as Chief Operating Officer, Fort Dodge from 2006 to 2007 and Executive Vice President and Chief Financial Officer from 2002 to 2006. since 2011.
Age 60
Tenure 13 years
Phone908 740 4000
Webhttps://www.merck.com

Merck Management Efficiency

The company has return on total asset (ROA) of 0.1268 % which means that it generated a profit of $0.1268 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.351 %, meaning that it generated $0.351 on every $100 dollars invested by stockholders. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities.
Merck Company has accumulated 30.69 B in total debt with debt to equity ratio (D/E) of 99.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Merck Company has a current ratio of 1.19, suggesting that it may not be capable to disburse its financial obligations in time and when they become due. Debt can assist Merck until it has trouble settling it off, either with new capital or with free cash flow. So, Merck's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Merck Company sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Merck to invest in growth at high rates of return. When we think about Merck's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Sumit SadanaMicron Technology
54
Michael VenSouthwest Airlines
61
Wayne WestDelta Air Lines
58
Jill PetersKB Home
N/A
Robert JordanSouthwest Airlines
62
Michael BokanMicron Technology
62
Rahul SamantDelta Air Lines
56
Joanne SmithDelta Air Lines
60
Steven SearDelta Air Lines
53
Paul JacobsonDelta Air Lines
47
Andrew WattersonSouthwest Airlines
56
Thomas NortonKB Home
52
Peter CarterDelta Air Lines
59
Joel PoppenMicron Technology
54
David ZinsnerMicron Technology
49
Scott DeBoerMicron Technology
57
April ArnzenMicron Technology
47
Manish BhatiaMicron Technology
51
Andrew IaboniMcEwen Mining
41
Tammy RomoSouthwest Airlines
61
It operates through four segments Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. MERCK INC operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. It employs 69000 people. Merck Company (MRK) is traded on Mexican Exchange in Mexico and employs 44 people.

Management Performance

Merck Company Leadership Team

Elected by the shareholders, the Merck's board of directors comprises two types of representatives: Merck inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck's management team and ensure that shareholders' interests are well served. Merck's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck's outside directors are responsible for providing unbiased perspectives on the board's policies.
Cristal Downing, Ex Officer
Jennifer Zachary, General Counsel
David Williams, Ex Officer
Caroline Litchfield, Ex CFO
Lisa LeCointeCephas, VP Officer
Richard DeLuca, Executive Vice President and Presidentident - Merck Animal Health
Kenneth Frazier, Chairman, CEO and Pres
Peter Dannenbaum, VP Relations
Jennifer Mauer, VP Communications
Robert JD, Pres Chairman

Merck Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Merck a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Merck Stock Analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.